Cancer Stem Cells as a Prognostic Biomarker and Therapeutic Target Using Curcumin/ Piperine Extract for Multiple Myeloma.

Sara A Mekkawy Mohga Shafik Abdalla Chetana Prakash DeshmukhRaafat AbdelfattahIbrahim M Abdel-Salam

Published in: Asian Pacific journal of cancer prevention : APJCP (2022)

MMCSCs in the bone marrow of MM-pCR patients can be utilized as a prognostic tool to predict recurrent multiple myeloma incidence. Also, the therapeutic potential of C/P extract as a prospective anti-MM drug targeting MMCSCs.

Keyphrases

multiple myeloma
bone marrow
cancer stem cells
end stage renal disease
oxidative stress
ejection fraction
chronic kidney disease
newly diagnosed
mesenchymal stem cells
risk factors
prognostic factors
emergency department
patient reported outcomes
cancer therapy
electronic health record
real time pcr